4
Total deals
$238.0M
Total value
$119.0M
Avg deal
$235.0M
Largest
| # | Acquired | Date | Type | Status | Price | |
|---|---|---|---|---|---|---|
| 1 |
Kolltan Pharmaceuticals
Kolltan Pharmaceuticals develops new-generation monoclonal antibody oncology the…
|
2016-11-01 | Acquisition | Complete | $235.0M | Deal → |
| 2 |
Curagen Corporation
CuraGen Corporation, a biopharmaceutical development company, develops novel the…
|
2009-10-01 | Acquisition | Complete | — | Deal → |
| 3 |
Lorantis
Lorantis develops products for the selective treatment of immunological and infl…
|
2005-11-01 | Acquisition | Complete | — | Deal → |
| 4 |
Alteris Therapeutics
Alteris Therapeutics engages in the discovery and development of therapeutics an…
|
2005-10-12 | — | Complete | $3.0M | Deal → |